<DOC>
	<DOCNO>NCT02720744</DOCNO>
	<brief_summary>The purpose study determine whether FT218 safe effective treatment excessive daytime sleepiness cataplexy subject narcolepsy .</brief_summary>
	<brief_title>Sodium Oxybate Treatment Excessive Daytime Sleepiness Cataplexy Narcolepsy</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Cataplexy</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>1 . Male female subject 16 year age old 2 . Willing able give write informed consent study participation . For young adult ( 16 17 year old ) reach age majority must capable give assent consent legally authorized guardian must obtain , required local law regulation 3 . Documented evidence diagnosis NT1 NT2 , part , determine overnight PSG nextday MSLT 2 SOREMPs mean sleep latency pathological range i.e . &lt; 8 minute meet NT1 NT2 define International Classification Sleep Disorders 3 criterion . 4 . Current continue presence EDS define subject report last 3 month ESS &gt; 10 5 . For NT1 , current continue presence cataplexy define subject report last 3 month 6 . Subjects may use concomitant stimulant , must comply follow : 1 . They must stable dose stimulant least 3 week prior start screen process study ; AND 2 . They must use stimulant regimen throughout entire study period , include screen posttreatment period 3 . They must discontinue anti cataplexy drug 7 . Addition inclusion criterion per protocol Exclusion criterion 1 . Any prior use sodium oxybate 2 . Current use sodium valproate 3 . Any use follow prohibited medication duration clinical study : 1 . Anticonvulsants 2 . Clonidine 3 . SSRIs serotonin norepinephrine reuptake inhibitor ( SNRIs ) 4 . MAOIs 5 . TCAs 6 . Hypnotics 7 . Anxiolytics 8 . Sedating antihistamine 9 . Antipsychotics 10 . Other experimental medication design treat narcolepsy , cataplexy condition 4 . Treatment investigational product within 3 month study enrollment 5 . Any drug know affect sleepwake function . Concomitant stimulant use permit 6 . Additional exclusion criterion per protocol</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>